We found for the first time a new origin of selection of perovskite crystallization pathways from DMF solutions containing MAI and PbI 2 to present here a comprehensive study of a full set of essential intermediate phases determining the perovskite's morphology. For all three discovered structurally different intermediate phases forming at a given precursor ratio, we refined their crystal structures by synchrotron X-ray radiation and investigated dynamics and phase assemblage in the course of decomposition. As a result, we revealed a clear correlation between the composition of the intermediate phases, peculiarities of their crystal structure, and the morphology of the final perovskite films. Using the DFT method we calculated formation enthalpies of these intermediate phases and explained the preferential precipitation of DMSO-adduct rather than DMF-adduct in an antisolvent approach. This finding opens up a possibility of design-on-demand of perovskite materials using simple soft chemistry approaches.
The chemical origin of solvents typically used for preparation of hybrid lead halide perovskitesdimethyl sulfoxide (DMSO), dimethylformamide (DMF), and γ-butyrolactone (GBL)strongly influences the process of perovskite crystallization because of the formation of intermediate adducts with different structures and morphology. The composition and crystal structures of the adducts depend on the coordination and binding ability of the solvents and the ratio of the precursors. New adducts of perovskite and GBL with either an unusual cluster structure, (MA) 8 (GBL) x [Pb 18 I 44 ], or an adduct, (MA) 2 (GBL) 2 Pb 3 I 8 , similar to those observed for DMF and DMSO are described for the first time. Complex equilibriums between chemical species existing in perovskite solutions are revealed by Raman spectroscopy. As a result, new features of the perovskite crystallization through intermediate adduct phases are discussed, and effective perovskite deposition pathways are suggested.
■ EXPERIMENTAL SECTIONMaterials and Methods. Methylammonium iodide (CH 3 NH 3 I = MAI, Dyesol), formamidinium iodide (CH 5 N 2 I = FAI, ≥98%, Dyesol), lead iodide (PbI 2 , 99%, Sigma-Aldrich), dimethyl sulfoxide
The molecular design of spin‐crossover complexes relies on controlling the spin state of a transition metal ion by proper chemical modifications of the ligands. Herein, the first N,N’‐disubstituted 2,6‐bis(pyrazol‐3‐yl)pyridines (3‐bpp) are reported that, against the common wisdom, induce a spin‐crossover in otherwise high‐spin iron(II) complexes by increasing the steric demand of a bulky substituent, an ortho‐functionalized phenyl group. As N,N’‐disubstituted 3‐bpp complexes have no pendant NH groups that make their spin state extremely sensitive to the environment, the proposed ligand design, which may be applicable to isomeric 1‐bpp or other families of popular bi‐, tri‐ and higher denticity ligands, opens the way for their molecular design as spin‐crossover compounds for future breakthrough applications.
Crystal structure, thermal behaviour and phase transitions of formamidinium iodide were studied by DTG, DSC, powder diffraction and X-ray crystallography.
The facile chemical precipitation method and subsequent thermal treatment were shown to be suitable for preparation of crystalline ThO2 nanoparticles (NPs) in a wide range of particle sizes (from 2.5 to 34.3 nm). The obtained NPs were investigated with X-ray diffraction, high-resolution transmission electron microscopy and X-ray absorption techniques to find out the possible size effects associated with nanocrystalline thoria. For 2.5 nm NPs, the lattice parameter of ThO2 was found to increase by up to 1.1 %, in comparison with the bulk material. The decrease in the particle size was also accompanied by a significant decrease in the Th-Th coordination number.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.